0001209191-22-051014.txt : 20220922 0001209191-22-051014.hdr.sgml : 20220922 20220922161452 ACCESSION NUMBER: 0001209191-22-051014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220920 FILED AS OF DATE: 20220922 DATE AS OF CHANGE: 20220922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RICHMAN ERIC I CENTRAL INDEX KEY: 0001313876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40237 FILM NUMBER: 221259378 MAIL ADDRESS: STREET 1: LEV PHARMACEUTICALS INC STREET 2: 122 EAST 42ND STREET STE 206 CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-20 0 0001819411 Gain Therapeutics, Inc. GANX 0001313876 RICHMAN ERIC I C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814 1 0 0 0 Employee Stock Option (right to buy) 3.50 2022-09-20 4 A 0 329400 0.00 A 2032-09-20 Common Stock 329400 329400 D Restricted Stock Units 2022-09-20 4 A 0 54900 0.00 A Common Stock 54900 54900 D The shares underlying the option shall vest fully on September 20, 2023, subject to Reporting Person's continuous service through such date. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest fully on September 20, 2023, subject to Reporting Person's continuous service through such date. /s/ Jason Minio, Attorney-in-Fact 2022-09-22